News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
684,678 Results
Type
Article (57202)
Company Profile (222)
Press Release (627254)
Section
Business (195459)
Career Advice (2904)
Deals (33703)
Drug Delivery (111)
Drug Development (81777)
Employer Resources (162)
FDA (17016)
Job Trends (14814)
News (337583)
Policy (33755)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (13)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (7)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2805)
Academic (2)
Accelerated approval (3)
Adcomms (27)
Allergies (78)
Alliances (51259)
ALS (82)
Alzheimer's disease (1381)
Antibody-drug conjugate (ADC) (107)
Approvals (16979)
Artificial intelligence (236)
Autoimmune disease (12)
Automation (13)
Bankruptcy (344)
Best Places to Work (11677)
BIOSECURE Act (21)
Biosimilars (96)
Biotechnology (159)
Bladder cancer (52)
Brain cancer (27)
Breast cancer (235)
Cancer (1844)
Cardiovascular disease (141)
Career advice (2443)
Career pathing (31)
CAR-T (140)
Cell therapy (404)
Cervical cancer (14)
Clinical research (65703)
Collaboration (729)
Compensation (274)
Complete response letters (26)
COVID-19 (2680)
CRISPR (36)
C-suite (189)
Cystic fibrosis (101)
Data (1723)
Decentralized trials (2)
Denatured (33)
Depression (42)
Diabetes (232)
Diagnostics (6260)
Digital health (18)
Diversity (7)
Diversity, equity & inclusion (41)
Drug discovery (112)
Drug pricing (113)
Drug shortages (29)
Duchenne muscular dystrophy (68)
Earnings (77165)
Editorial (32)
Employer branding (21)
Employer resources (144)
Events (97982)
Executive appointments (610)
FDA (18011)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (651)
Gene editing (93)
Generative AI (26)
Gene therapy (289)
GLP-1 (726)
Government (4447)
Grass and pollen (4)
Guidances (44)
Healthcare (18810)
Huntington's disease (19)
IgA nephropathy (19)
Immunology and inflammation (97)
Indications (23)
Infectious disease (2806)
Inflammatory bowel disease (133)
Inflation Reduction Act (9)
Influenza (44)
Intellectual property (74)
Interviews (547)
IPO (15529)
IRA (44)
Job creations (3628)
Job search strategy (2023)
Kidney cancer (10)
Labor market (21)
Layoffs (425)
Leadership (19)
Legal (8009)
Liver cancer (72)
Lung cancer (267)
Lymphoma (122)
Machine learning (2)
Management (54)
Manufacturing (253)
MASH (56)
Medical device (12623)
Medtech (12627)
Mergers & acquisitions (18572)
Metabolic disorders (615)
Multiple sclerosis (65)
NASH (20)
Neurodegenerative disease (80)
Neuropsychiatric disorders (22)
Neuroscience (1837)
NextGen: Class of 2025 (6654)
Non-profit (4744)
Northern California (2027)
Now hiring (20)
Obesity (338)
Opinion (249)
Ovarian cancer (60)
Pain (79)
Pancreatic cancer (70)
Parkinson's disease (120)
Partnered (18)
Patents (184)
Patient recruitment (82)
Peanut (47)
People (55375)
Pharmaceutical (57)
Pharmacy benefit managers (17)
Phase I (20245)
Phase II (28698)
Phase III (21891)
Pipeline (815)
Podcasts (91)
Policy (114)
Postmarket research (2818)
Preclinical (8765)
Press Release (64)
Prostate cancer (87)
Psychedelics (35)
Radiopharmaceuticals (252)
Rare diseases (360)
Real estate (5513)
Recruiting (68)
Regulatory (23196)
Reports (33)
Research institute (2543)
Resumes & cover letters (467)
Rett syndrome (2)
RNA editing (1)
RSV (40)
Schizophrenia (65)
Series A (114)
Series B (69)
Service/supplier (5)
Sickle cell disease (50)
Southern California (1794)
Special edition (16)
Sponsored (30)
Startups (3447)
State (2)
Stomach cancer (11)
Supply chain (60)
The Weekly (57)
United States (18773)
Vaccines (677)
Venture capitalists (32)
Webinars (10)
Weight loss (243)
Women's health (33)
Worklife (16)
Date
Today (164)
Last 7 days (752)
Last 30 days (2962)
Last 365 days (34031)
2025 (5749)
2024 (34805)
2023 (39111)
2022 (50065)
2021 (54347)
2020 (53251)
2019 (46746)
2018 (35457)
2017 (32940)
2016 (32289)
2015 (37159)
2014 (30534)
2013 (26776)
2012 (28121)
2011 (28292)
2010 (26910)
Location
Africa (959)
Alabama (49)
Alaska (7)
Arizona (166)
Arkansas (12)
Asia (41528)
Australia (7033)
California (4707)
Canada (1729)
China (418)
Colorado (228)
Connecticut (241)
Delaware (113)
Europe (93097)
Florida (741)
Georgia (168)
Idaho (55)
Illinois (474)
India (20)
Indiana (271)
Iowa (6)
Japan (127)
Kansas (93)
Kentucky (23)
Louisiana (10)
Maine (67)
Maryland (743)
Massachusetts (3683)
Michigan (199)
Minnesota (307)
Mississippi (2)
Missouri (76)
Montana (30)
Nebraska (25)
Nevada (51)
New Hampshire (63)
New Jersey (1430)
New Mexico (27)
New York (1412)
North Carolina (910)
North Dakota (8)
Northern California (2027)
Ohio (174)
Oklahoma (14)
Oregon (34)
Pennsylvania (1084)
Puerto Rico (7)
Rhode Island (22)
South America (1281)
South Carolina (14)
South Dakota (1)
Southern California (1794)
Tennessee (81)
Texas (710)
Utah (158)
Virginia (123)
Washington D.C. (57)
Washington State (480)
West Virginia (3)
Wisconsin (45)
684,678 Results for "fraunhofer institute for toxicology and experimental medicine item".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
February 24, 2025
·
3 min read
Press Releases
Alveo Technologies and Fraunhofer Partner to Develop First-of-its-Kind Rapid, Molecular Feline Respiratory Panel Diagnostic
December 11, 2024
·
3 min read
Press Releases
Schrödinger Broadens and Accelerates Predictive Toxicology Initiative
November 18, 2024
·
5 min read
BioMidwest
Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the California Institute for Regenerative Medicine (CIRM) Accelerating Medicines Partnership (AMP) Bespoke Gene Therapy Consortium (BGTC)
Andelyn Biosciences, Inc. has been selected to manufacture adeno-associated vectors therapies using its suspension AAV Curator™ Platform under the California Institute for Regenerative Medicine Accelerating Medicines Partnership Bespoke Gene Therapy Consortium.
May 23, 2024
·
3 min read
Biotech Beach
Simulations Plus Extends Collaboration with Major Toxicology Research Agency
Simulations Plus, Inc. announced an extension to the formal agreement with the Translational Toxicology Division at the National Institute of Environmental Health Sciences to support the rapid safety assessment of chemicals in animals and humans.
February 15, 2024
·
5 min read
Press Releases
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine
February 3, 2025
·
8 min read
Press Releases
CN Bio Launches PhysioMimix DILI Assay Kit: Human 24, for Enhanced Preclinical Toxicology Testing
February 4, 2025
·
3 min read
Business
EnGeneIC and Singapore Institute of Advanced Medicine Holdings Forge Strategic Partnership to Revolutionise Cancer Treatment in Asia
EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has announced strategic partnerships with Singapore Institute of Advanced Medicine Holdings and Singapore Medical Incorporation.
June 6, 2024
·
3 min read
Press Releases
Feinstein Institutes, Bioelectronic Medicine honor three University of Texas at Dallas researchers with 2024 Cerami Award
February 4, 2025
·
5 min read
Pancreatic cancer
Revolution Medicines Targets Hard-to-Treat Pancreatic Cancer With Two Early-Phase Readouts
Jefferies analyst Kelly Shi in a Sunday note to investors said that both data drops for Revolution Medicines’ experimental RAS inhibitors are positive and could be “synergistic” in the first-line setting for pancreatic ductal adenocarcinoma.
October 28, 2024
·
2 min read
·
Tristan Manalac
1 of 68,468
Next
